VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 3 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,447 | -48.1% | 15,391 | +33.3% | 0.00% | – |
| Q2 2023 | $291,843 | +7.5% | 11,549 | +13.4% | 0.00% | – |
| Q4 2022 | $271,377 | -11.9% | 10,183 | -0.9% | 0.00% | – |
| Q3 2022 | $308,000 | +41.9% | 10,273 | +26.2% | 0.00% | – |
| Q2 2022 | $217,000 | -97.6% | 8,141 | -96.0% | 0.00% | -100.0% |
| Q3 2021 | $8,934,000 | +12138.4% | 205,896 | +12516.2% | 0.00% | – |
| Q1 2021 | $73,000 | -71.3% | 1,632 | -81.9% | 0.00% | – |
| Q4 2020 | $254,000 | +109.9% | 9,014 | +209.4% | 0.00% | – |
| Q3 2020 | $121,000 | -34.2% | 2,913 | -25.0% | 0.00% | – |
| Q2 2020 | $184,000 | +1433.3% | 3,886 | +886.3% | 0.00% | – |
| Q1 2020 | $12,000 | +9.1% | 394 | -56.5% | 0.00% | – |
| Q4 2019 | $11,000 | – | 905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |